Skip to content

Bill Schiffner

NACDS hotline rallies industry to urge DIR relief

NACDS hotline rallies industry to urge DIR relief

With the Senate Finance Committee expected to begin making decisions on spending bills as early as today, the National Association of Chain Drug Stores has launched a telephone hotline — (866) DIR-RE4M — that pharmacy advocates can use to urge the inclusion of DIR fee relief in drug-pricing legislat

For American patients to be put first, DIR fee relief is essential

The following was a post Monday from NACDS president and chief executive officer Steven Anderson on Medium urging action on DIR fee relief in final Medicare rule: We may be just days from learning whether a pending Medicare rule will provide relief from pharmacy direct and indirect remuneration (DIR

How to get out from the suffocating miasma of DIR fees

The direct and indirect remuneration (DIR) component of Medicare Part D programs today is very complicated and has been implemented in a variety of ways. The lack of clarity, fairness and transparency to all parties has created business challenges for pharmacies.

Consumers embrace new healthy living mindsets

It’s hard to miss the heightened shopper interest in health and wellness these days. In our recent “How America Shops” study, The Big Business of WELL, many shoppers showed they are committed to being well: 42% said that while it costs more to “live healthy,” it’s worth it.

Sera Labs: a thriving CBD company with a difference

The retail market for products containing CBD is projected to expand rapidly in the coming years amid the growing acceptance of hemp and cannabis across the country. One of the up-and-coming companies in this category is Sera Labs.